Senator john mccain's health status and the arrogance of preventive medicine

Journal of the American Geriatrics Society

Volumn 57, Issue 4, 2009, Pages 739-740

  Mascitelli, Luca ^a   Pezzetta, Francesca ^b  

^a Medical Service   (Italy)

^b Ospedale Civile di Tolmezzo   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

SIMVASTATIN; TRANSCRIPTION FACTOR FOXP3;

ATHEROMA; ATHEROSCLEROTIC PLAQUE; CANCER CELL; CANCER GROWTH; CANCER INCIDENCE; CARDIOVASCULAR DISEASE; CELL FUNCTION; CELL INVASION; DISEASE COURSE; DRUG RESPONSE; DYSLIPIDEMIA; HEALTH STATUS; HIGH RISK PATIENT; HUMAN; IMMUNE RESPONSE; IMMUNITY; LETTER; MELANOMA; MORBIDITY; MORTALITY; PREVENTIVE MEDICINE; REGULATORY T LYMPHOCYTE;

FAMOUS PERSONS; HEALTH STATUS; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; MELANOMA; POLITICS; PREVENTIVE MEDICINE; UNITED STATES;

EID: 63849296874     PISSN: 00028614     EISSN: 15325415     Source Type: Journal    
DOI: 10.1111/j.1532-5415.2009.02213.x     Document Type: Letter

References (6)

1. McCain in 'Excellent Health,' Doctor Says [on-line]. Available at Accessed November 7, 2008.
2. Alam J. US Senator John McCain and risk of melanoma-associated mortality. Lancet 2008 372 : 1462.
3. Statement of Health Status: Prepared by Mayo Clinic at the Request of Senator John McCain, [on-line]. Available at accessed November 7, 2008.
4. Goldstein MR, Mascitelli L, Pezzetta F. Statin therapy in the elderly: Misconceptions. J Am Geriatr Soc 2008 56 : 1365.
5. Mausner-Fainberg K, Luboshits G, Mor A et al. The effect of HMG-CoA reductase inhibitors on naturally occurring CD4+CD25+T cells. Atherosclerosis 2008 19 : 829 839.
6. Mourmouras V, Fimiani M, Rubegni P et al. Evaluation of tumour-infiltrating CD4+CD25+FOXP3+regulatory T cells in human cutaneous benign and atypical naevi, melanomas and melanoma metastases. Br J Dermatol 2007 157 : 531 539.